We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.

Cell | Dec 1, 2016

Poorly immunogenic tumor cells evade host immunity and grow even in the presence of an intact immune system, but the complex mechanisms regulating tumor immunogenicity have not been elucidated. Here, we discovered an unexpected role of the Hippo pathway in suppressing anti-tumor immunity. We demonstrate that, in three different murine syngeneic tumor models (B16, SCC7, and 4T1), loss of the Hippo pathway kinases LATS1/2 (large tumor suppressor 1 and 2) in tumor cells inhibits tumor growth. Tumor regression by LATS1/2 deletion requires adaptive immune responses, and LATS1/2 deficiency enhances tumor vaccine efficacy. Mechanistically, LATS1/2-null tumor cells secrete nucleic-acid-rich extracellular vesicles, which induce a type I interferon response via the Toll-like receptors-MYD88/TRIF pathway. LATS1/2 deletion in tumors thus improves tumor immunogenicity, leading to tumor destruction by enhancing anti-tumor immune responses. Our observations uncover a key role of the Hippo pathway in modulating tumor immunogenicity and demonstrate a proof of concept for targeting LATS1/2 in cancer immunotherapy.

Pubmed ID: 27912060 RIS Download

Mesh terms: Animals | Cancer Vaccines | Gene Deletion | Immune Tolerance | Immunotherapy | Mice | Mice, Inbred BALB C | Mice, Inbred C3H | Mice, Inbred C57BL | Neoplasms | Protein-Serine-Threonine Kinases | Signal Transduction | Toll-Like Receptors | Tumor Suppressor Proteins

Research tools detected in this publication

Data used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, Id: HHSN272201400051C
  • Agency: NEI NIH HHS, Id: R01 EY022611
  • Agency: NIGMS NIH HHS, Id: R01 GM051586
  • Agency: NCI NIH HHS, Id: R35 CA196878

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Graphpad Prism

Statistical software package for data analysis, hypothesis testing, and modeling. The software can capable perform mathematical calculations (including biostatistics) and graphical plotting such as curve fitting (nonlinear regression) and scientific graphing.

tool

View all literature mentions

FlowJo

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

tool

View all literature mentions

Proteome Discoverer

Software for identifying, characterizing, and quantifying proteins in biological samples. It can be used for a range of proteomics workflows such as protein and peptide identification, PTM analysis, and isobaric mass tagging for quantification. It supports multiple database search algorithms and multiple dissociation techniques.

tool

View all literature mentions